The VDAC1-based peptide, R-Tf-D-LP4, was tested in several cancer types and found to simultaneously attack several hallmarks of cancer, causing impairment of energy, metabolic homeostasis, inhibition of tumor growth, induction of apoptosis, and overexpression of apoptotic proteins [18,26]. The gene discussed is VDAC1; the disease is neoplasm.